OBESITY CONFERENCE

31 January - 1 February 2018

 CME Points TBA

Overview

For the first time in 2018, the Arab Health Congress will introduce the Obesity Conference – a timely and relevant forum for clinicians in the region where prevalence of the disease has reached epidemic proportions.

Obesity is a leading preventable cause of death worldwide and considered to be one of the most serious public health problems of the 21st century. Globally, it is the fifth leading risk for premature death with almost three million adults dying every year. Due to the steady increase in the consumption of fast foods and sugar-dense beverages as well as a decrease in levels of activity, obesity cases have become commonplace for primary care and specialised practitioners in the Gulf region.

The Obesity Conference will put the spotlight the management and treatment of the associated health risks as well as the preventive measures that healthcare practitioners can put into effect to minimize the epidemic. Furthermore, it will bring together research findings that support treatment and management of obesity through non-surgical methods.

What are the main topics covered in this event?

  • Medical care of the post-surgery bariatric patient
  • Pharmacotherapy
  • Weight loss supplements and pills
  • Lifestyle/behavioral counselling
  • Childhood obesity and nutrition
  • Thyroid and obesity

What is new for 2018?

  • New conference Chair
  • Pharmacotherapy session

Benefits of attending

  • Discuss the key challenges around obesity in the region and explain their potential clinical implications
  • Investigate approaches for prevention and management practices in an integrated and cross-disciplinary environment and identify strategies for evaluation and treatment
  • Learn about the current prevention strategies and interventions in place and the clinical treatment in practice that you can utilise in your practice
  • Review the most recent evidence-based practice in the medical care of the post-surgery bariatric patient
  • Compare efficacy and side effects of pharmacologic treatments for obesity and describe their clinical role in weight-loss strategies
  • Demonstrate knowledge and competence to counsel patients on diet selection, cooking techniques, and behavioral modification as practical weight-loss strategies

Conference Chair
Dr Nadia Ahmad,
Founding Director, Obesity Medicine Institute, Dubai, UAE

Activity Director
Dr Matthew Kroh,
MD, Surgeon; Chief of the Digestive Disease Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE

Scientific committee

  • Dr Nasreen Alfaris, Founding Director, Center for Obesity Medicine, Riyadh, Saudi Arabia
  • Dr Lee M. Kaplan, Director, Obesity Metabolism & Nutrition Institute, Massachusetts General Hospital; Associate Professor of Medicine, Harvard Medical School, Boston, MA, USA

Disclaimer: The UAE has announced that it will introduce VAT on 1 January 2018 at a rate to be determined (currently expected to be 5%). Any delegate fees for events taking place in 2018 may be subject to this VAT and we are waiting for the legislation to be finalised and further guidance issued. Any applicable VAT will be invoiced in addition to the prices mentioned on the registration form.

09:20    Opening remarks

               Dr Nadia Ahmad, Founding Director, Obesity Medicine Institute, Dubai, UAE

 

SESSION 1: KEYNOTE

Moderator: Dr Nadia Ahmad, Founding Director, Obesity Medicine Institute, Dubai, UAE

KEY QUESTION: WHAT'S CHANGED OVER THE PAST 20 YEARS?

09:30     State of obesity care

               Prof Lee M. Kaplan, Director - Obesity Metabolism & Nutrition Institute, Massachusetts General Hospital; Associate Professor of Medicine, Harvard Medical                  School, Boston, Massachusetts, USA

 

SESSION 2: PATHOPHYSIOLOGY OF OBESITY - GENETIC AND EPIGENETIC EFFECTS

Moderator: Prof Lee Kaplan, Director - Obesity Metabolism & Nutrition Institute, Massachusetts General Hospital; Associate Professor of Medicine, Harvard Medical School, Boston, Massachusetts, USA

KEY  QUESTION 2: CAN A SOCIAL EPIDEMIC BE ROOTED IN GENETICS?

10:15     Genetics of obesity

               Prof Alexandra Blakemore, Prof of Human Molecular Genetics, Imperial College London, London, UK

10:45     Early nutrition and epigenetics: The key role in obesity protection

               Prof Hadia Radwan, Assistant Prof - Clinical Nutrition and Dietetics, College of Health Sciences, University of Sharjah, Sharjah, UAE

11:15     Coffee Break

 

SESSION 3: PATHOPHYSIOLOGY OF OBESITY - REDEFINING THE ENVIRONMENT

Moderator: Prof Lee M. Kaplan, Director - Obesity Metabolism & Nutrition Institute, Massachusetts General Hospital; Associate Professor of Medicine, Harvard Medical School, Boston, Massachusetts, USA

KEY QUESTION 3: WHAT'S GONE WRONG WITH OUR WORLD BEYOND FOOD AND SCREEN TIME?

11:45     Environmental modulators of obesity

               Dr Nadia Ahmad, Founding Director, Obesity Medicine Institute, Dubai, UAE

12:15     The role of microbiota in obesity 

               Prof Max Nieuwdorp, Internist-Endocrinologist; Head - Department of Amsterdam Diabetes Centre, AMC/VUmC, University of Amsterdam, Amsterdam,                  Netherlands

12:45     Q & A

13:00     Lunch Break

 

SESSION 4: LIFESTYLE THERAPIES FOR OBESITY: FOOD, ACTIVITY & SLEEP AS MEDICINE

Moderator: Dr Nasreen Alfaris, Founding Director, Centre for Obesity Medicine, Riyadh, KSA

KEY QUESTION 4: CAN LIFESTYLE THERAPIES REVERSE THE PATHOPHYSIOLOGY OF OBESITY

14:15     Revisiting nutrition as therapy for obesity   

               Claire Julsing Strydom, Dietitian, Nutritional Solutions, Johannesburg, South Africa

14:45     The role of exercise in obesity

               Dr Assim Alfadda, Founder & Director, Obesity Research Centre,King Saud University, KSA

15:15     Sleep and circadian rhythm

               Dr Sabina Aidarous, Family Medicine Specialist, Medicentre, Dubai, UAE

15:45     Coffee Break

 

SESSION 5: THE FORGOTTEN MODIFIABLE FACTORS: STRESS AND MEDICATIONS

Moderator: Dr Nasreen Alfaris, Founding Director, Centre for Obesity Medicine, Riyadh, KSA

KEY QUESTION 5:HOW CAN OTHER MODIFIABLE FACTORS IMPACT THE ADIPOSITY SET POINT?

16:15     Stress management for obesity 

               Dr Valentina Faia, Adult Psychiatrist & Obesity Specialist, Lighthouse Arabia, Dubai, UAE

16:45     Weight gain-promoting medications

               Dr Nasreen Alfaris, Founding Director, Centre for Obesity Medicine, Riyadh, KSA

17:15     Q & A

17:30     End of Day One

08:45     Opening remarks

               Dr Nadia Ahmad, Founding Director, Obesity Medicine Institute, Dubai, UAE

 

SESSION 6: PHARMACOLOGIC AND DEVICE-BASED THERAPIES FOR OBESITY

Moderator:  Dr Noor Al Busaidi, Chairperson, Oman Diabetes Association; Director, National Diabetes & Endocrine Centre, Muscat, Oman

KEY QUESTION 6: CAN OBESITY EFFECTIVELY & SAFELY BE MANAGED WITH DRUGS AND DEVICES?

09:00     Anti-obesity medications

               Speaker to be confirmed

09:30     Combination therapy for obesity   

               Dr Nadia Ahmad, Founding Director, Obesity Medicine Institute, Dubai, UAE

10:00     Device-based therapies for obesity   

               Dr Matthew Kroh, Institute Chief - Digestive Disease Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE

10:30     Q & A

10:40     Coffee Break

 

SESSION 7:  SURGICAL THERAPY FOR OBESITY I: EVOLUTION OF PROCEDURES & HOW THEY WORK

Moderator:  Dr Matthew Kroh, Institute Chief - Digestive Disease Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE

KEY QUESTION 7: WHY BARIATRIC SURGERY HAS A NEW NAME?

11:10     Mechanisms of surgery

               Prof Lee M. Kaplan, Director - Obesity Metabolism & Nutrition Institute, Massachusetts General Hospital; Associate Professor of Medicine, Harvard Medical School,                  Boston, Massachusetts, USA

11:40     Regional evolution of obesity surgery, VSG and RYGB      

               Dr Abdelrahman Nimeri, Director, Bariatric and Metabolic Institute, Abu Dhabi; Chief, Division of General Thoracic and Vascular Surgery, Sheikh Khalifa Medical                  City, Abu Dhabi, UAE

12:10     Revisional surgery

               Dr Kelvin Higa, President, International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO), Medical Director, Fresno Bariatrics, Fresno,                  California, USA

12:40     Q & A

12:50     Lunch Break

 

SESSION 8:  SURGICAL THERAPY FOR OBESITY II

Moderator: Dr Kelvin Higa, President, International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO), Medical Director, Fresno Bariatrics, Fresno, California, USA

KEY QUESTION 8: WHAT DOES IT TAKE TO DO SURGERY 'RIGHT' IN THIS REGION?

14:15     Multidisciplinary care of the surgical patient

               Dr Mohammed Al Hadad, Consultant Bariatric Surgeon, Healthpoint, Abu Dhabi, UAE             

14:45     Role of primary care: Patient selection and long-term follow up

               Dr Nasreen Alfaris, Founding Director, Centre for Obesity Medicine, Riyadh, KSA

15:15     Suboptimal response to surgery and combinatorial approaches

               Dr Nadia Ahmad, Founding Director, Obesity Medicine Institute, Dubai, UAE

15:45     Q & A

16:00     Closing remarks

               Dr Nadia Ahmad, Founding Director, Obesity Medicine Institute, Dubai, UAE

16:15     End of Conference

CONFERENCE CHAIR:

Dr Nadia Ahmad, Founding Director, Obesity Medicine Institute, Dubai, UAE

 

SCIENTIFIC COMMITTEE:

Prof Lee Kaplan, Director - Obesity Metabolism & Nutrition Institute, Massachusetts General Hospital; Associate Professor of Medicine, Harvard Medical School, Boston, Massachusetts, USA

Dr Nasreen Alfaris, Founding Director, Centre for Obesity Medicine, Riyadh, KSA

 

SPEAKER FACULTY:

Dr Abdelrahman Nimeri, Director, Bariatric and Metabolic Institute, Abu Dhabi; Chief, Division of General Thoracic and Vascular Surgery, Sheikh Khalifa Medical City, Abu Dhabi, UAE

Prof Alexandra Blakemore, Prof - Human Molecular Genetics, Imperial College London, London, UK

Dr Assim Alfadda, Founder & Director, Obesity Research Centre, ‎King Saud University, KSA

Claire Julsing Strydom, Dietitian, Nutritional Solutions, Johannesburg, South Africa

Prof Hadia Radwan, Assistant Prof - Clinical Nutrition and Dietetics, College of Health Sciences, University of Sharjah, Sharjah, UAE

Dr Kelvin Higa, President, International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO), Medical Director, Fresno Bariatrics, Fresno, California, USA

Prof Max Nieuwdorp, Internist-Endocrinologist; Head - Department of Amsterdam Diabetes Centre, AMC/VUmC, University of Amsterdam, Amsterdam, Netherlands

Dr Mohammed Al Hadad, Consultant Bariatric Surgeon, Healthpoint, Abu Dhabi, UAE

Dr Noor Albusaidi, President, Oman Diabetes Association; Director, National Diabetes and Endocrine Centre, Muscat, Oman

Dr Sabina Aidarous, Family Medicine Specialist, Medicentre, Dubai, UAE

Dr Valentina Faia, Adult Psychiatrist & Obesity Specialist, Lighthouse Arabia, Dubai, UAE